Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
-0.59%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$44.1B
AUM Growth
+$44.1B
(-4.1%)
Cap. Flow
-$601M
Cap. Flow
% of AUM
-1.36%
Top 10 Holdings %
Top 10 Hldgs %
24.82%
Holding
982
New
120
Increased
284
Reduced
352
Closed
123
Top Buys
| 1 |
Emerson Electric
EMR
|
$195M |
| 2 |
ATVI
Activision Blizzard Inc.
ATVI
|
$155M |
| 3 |
Dover
DOV
|
$123M |
| 4 |
Honeywell
HON
|
$118M |
| 5 |
Chevron
CVX
|
$112M |
Top Sells
| 1 |
Boeing
BA
|
$247M |
| 2 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$180M |
| 3 |
Johnson Controls International
JCI
|
$148M |
| 4 |
Lockheed Martin
LMT
|
$148M |
| 5 |
Republic Services
RSG
|
$137M |
Sector Composition
| 1 | Technology | 25.68% |
| 2 | Healthcare | 17.45% |
| 3 | Financials | 11.47% |
| 4 | Consumer Discretionary | 9.72% |
| 5 | Industrials | 9.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Palo Alto Networks
PANW
$127B
| $81.4M | 0.18% |
347,100
+70,600
| +26% | +$16.6M |
|
127
GE Aerospace
GE
$292B
| $81.2M | 0.18% |
734,720
+360,210
| +96% | +$39.8M |
|
128
Charles Schwab
SCHW
$174B
| $81.2M | 0.18% |
1,478,439
-2,200
| -0.1% | -$121K |
|
129
Applied Materials
AMAT
$128B
| $80.8M | 0.18% |
583,688
-167,700
| -22% | -$23.2M |
|
130
Union Pacific
UNP
$133B
| $80M | 0.18% |
392,914
-214,500
| -35% | -$43.7M |
|
131
Citigroup
C
$178B
| $78.8M | 0.18% |
1,914,686
-25,000
| -1% | -$1.03M |
|
132
Progressive
PGR
$145B
| $78.3M | 0.18% |
561,985
-421,200
| -43% | -$58.7M |
|
133
Regeneron Pharmaceuticals
REGN
$61.5B
| $78M | 0.18% |
94,749
-43,300
| -31% | -$35.6M |
|
134
American Tower
AMT
$95.5B
| $76.2M | 0.17% |
463,505
-800
| -0.2% | -$132K |
|
135
Blackstone
BX
$134B
| $75.6M | 0.17% |
+705,700
| New | +$75.6M |
|
136
Everest Group
EG
$14.3B
| $75.5M | 0.17% |
203,181
-149,500
| -42% | -$55.6M |
|
137
Arthur J. Gallagher & Co
AJG
$77.6B
| $75.1M | 0.17% |
329,303
-484,100
| -60% | -$110M |
|
138
Sempra
SRE
$53.9B
| $74.5M | 0.17% |
1,095,670
+584,685
| +114% | +$39.8M |
|
139
Humana
HUM
$36.5B
| $74.4M | 0.17% |
152,860
+147,320
| +2,659% | +$71.7M |
|
140
Altria Group
MO
$113B
| $74.2M | 0.17% |
1,764,432
-14,100
| -0.8% | -$593K |
|
141
Sherwin-Williams
SHW
$91.2B
| $72.7M | 0.16% |
285,206
+51,400
| +22% | +$13.1M |
|
142
Roivant Sciences
ROIV
$8.15B
| $72.4M | 0.16% |
6,200,000
-4,890,300
| -44% | -$57.1M |
|
143
Aptiv
APTV
$17.3B
| $72.1M | 0.16% |
731,200
-38,300
| -5% | -$3.78M |
|
144
T-Mobile US
TMUS
$284B
| $72.1M | 0.16% |
514,634
-59,200
| -10% | -$8.29M |
|
145
CME Group
CME
$96B
| $71.6M | 0.16% |
357,631
-800
| -0.2% | -$160K |
|
146
Fortive
FTV
$16.2B
| $71.4M | 0.16% |
963,450
-1,204,318
| -56% | -$89.3M |
|
147
Cigna
CI
$80.3B
| $70.7M | 0.16% |
247,195
-180,654
| -42% | -$51.7M |
|
148
Stryker
SYK
$150B
| $69.5M | 0.16% |
254,236
-124,179
| -33% | -$33.9M |
|
149
TopBuild
BLD
$11.8B
| $69.2M | 0.16% |
275,000
+125,000
| +83% | +$31.5M |
|
150
Sarepta Therapeutics
SRPT
$1.78B
| $67.9M | 0.15% |
560,000
-95,000
| -15% | -$11.5M |
|